Full Text View
Tabular View
No Study Results Posted
Related Studies
Risperidone Long-Acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
This study is ongoing, but not recruiting participants.
Study NCT00130923.   Last updated on March 4, 2009.
Information provided by Dartmouth-Hitchcock Medical Center
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Psychotic Disorders
Substance Abuse
Alcohol Abuse
Additional conditions recognized in this trial
Alcoholism
Disease
Substance-Related Disorders
More general conditions related to this trial
Alcohol-Related Disorders
Disorders of Environmental Origin
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
risperidone long-acting
oral risperidone
Additional drug interventions recognized in this trial
Risperidone
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Dartmouth-Hitchcock Medical Center
Janssen, LP


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services